title: Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.
abstract: Although the efficacy of methadone maintenance treatment (MMT) in opioid dependence disorder has been well established, the influence of methadone pharmacokinetics in dose requirement and clinical outcome remains controversial. The aim of this study is to analyze methadone dosage in responder and nonresponder patients considering pharmacogenetic and pharmacokinetic factors that may contribute to dosage adequacy. Opioid dependence patients (meeting Diagnostic and Statistical Manual of Mental Disorders, [4(th) Edition] criteria) from a MMT community program were recruited. Patients were clinically assessed and blood samples were obtained to determine plasma concentrations of (R,S)-, (R) and (S)-methadone and to study allelic variants of genes encoding CYP3A5, CYP2D6, CYP2B6, CYP2C9, CYP2C19, and P-glycoprotein. Responders and nonresponders were defined by illicit opioid consumption detected in random urinalysis. The final sample consisted in 105 opioid dependent patients of Caucasian origin. Responder patients received higher doses of methadone and have been included into treatment for a longer period. No differences were found in terms of genotype frequencies between groups. Only CYP2D6 metabolizing phenotype differences were found in outcome status, methadone dose requirements, and plasma concentrations, being higher in the ultrarapid metabolizers. No other differences were found between phenotype and responder status, methadone dose requirements, neither in methadone plasma concentrations. Pharmacokinetic factors could explain some but not all differences in MMT outcome and methadone dose requirements.
authors: Institut de Neuropsiquiatria i Addiccions-Parc de Salut Mar, Barcelona, Spain.
authors: Francina
authors: F
authors: Fonseca
authors: Rafael
authors: R
authors: de la Torre
authors: Laura
authors: L
authors: Díaz
authors: Antonio
authors: A
authors: Pastor
authors: Elisabet
authors: E
authors: Cuyàs
authors: Nieves
authors: N
authors: Pizarro
authors: Olha
authors: O
authors: Khymenets
authors: Magí
authors: M
authors: Farré
authors: Marta
authors: M
authors: Torrens
references: Int J Clin Pharmacol Ther. 2007 Jul;45(7):410-7
references: 17725248
references: Proc Natl Acad Sci U S A. 1987 Jan;84(1):265-9
references: 2432605
references: J Nerv Ment Dis. 1980 Jan;168(1):26-33
references: 7351540
references: Clin Pharmacokinet. 2009;48(12):761-804
references: 19902987
references: Drug Alcohol Depend. 2006 Jul 27;83(3):218-24
references: 16384657
references: Addict Biol. 2011 Jan;16(1):142-4
references: 21158011
references: Curr Drug Metab. 2008 Sep;9(7):598-610
references: 18781911
references: Brain Res Rev. 2009 Dec 11;62(1):127-46
references: 19804796
references: Pharmacology. 2007;80(4):304-11
references: 17690563
references: J Pharmacol Exp Ther. 2007 Apr;321(1):389-99
references: 17259447
references: Pharmacogenetics. 2004 Dec;14(12):793-804
references: 15608558
references: Ther Drug Monit. 2004 Apr;26(2):192-9
references: 15228164
references: Clin Pharmacol Ther. 2006 Dec;80(6):682-90
references: 17178268
references: Drug Alcohol Depend. 1998 Nov 1;52(3):193-200
references: 9839145
references: J Clin Psychopharmacol. 2001 Apr;21(2):229-34
references: 11270921
references: Clin Pharmacol Ther. 2006 Jul;80(1):51-60
references: 16815317
references: J Clin Psychopharmacol. 2002 Apr;22(2):211-5
references: 11910269
references: Drug Metab Dispos. 2003 Jun;31(6):742-7
references: 12756206
references: Psychiatr Serv. 2001 Sep;52(9):1230-6
references: 11533398
references: Anesthesiology. 2008 Mar;108(3):363-74
references: 18292673
references: Mol Diagn Ther. 2008;12(2):109-24
references: 18422375
references: Mol Diagn Ther. 2009;13(5):331-7
references: 19791836
references: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3473-8
references: 10716719
references: J Psychoactive Drugs. 1999 Apr-Jun;31(2):95-102
references: 10437990
references: Chem Res Toxicol. 1996 Mar;9(2):365-73
references: 8839037
references: CMAJ. 2006 Jun 6;174(12):1715-22
references: 16754899
references: Clin Pharmacol Ther. 2005 Dec;78(6):593-604
references: 16338275
references: Clin Infect Dis. 2007 Nov 1;45(9):1230-7
references: 17918089
references: Neuropharmacology. 2008 Dec;55(7):1147-55
references: 18687346
references: Pharmacogenetics. 2001 Jul;11(5):399-415
references: 11470993
references: Br J Clin Pharmacol. 2003 Aug;56(2):220-4
references: 12895196
references: Life Sci. 1995;56(2):PL45-50
references: 7823756
references: Drug Metab Rev. 2002 Feb-May;34(1-2):83-448
references: 11996015
references: Clin Pharmacol Ther. 2008 May;83(5):668-9; author reply 669-70
references: 18043693
references: Am J Drug Alcohol Abuse. 2008;34(4):355-81
references: 18584566
references: Chirality. 2004 Jan;16(1):36-44
references: 14628297
references: Clin Lab Med. 2008 Dec;28(4):581-98
references: 19059064
references: Drug Alcohol Depend. 2000 Dec 22;61(1):47-54
references: 11064183
references: Nat Genet. 2001 Apr;27(4):383-91
references: 11279519
references: Pharmacogenetics. 2001 Dec;11(9):773-9
references: 11740341
references: Acta Anaesthesiol Scand. 2004 Nov;48(10):1232-9
references: 15504181
references: Fundam Clin Pharmacol. 2010 Apr;24(2):247-53
references: 19682083
references: J Clin Psychopharmacol. 1997 Apr;17(2):113-7
references: 10950475
references: J Pharm Biomed Anal. 1990;8(8-12):905-9
references: 2100640
references: Clin Pharmacol Ther. 2006 Dec;80(6):668-81
references: 17178267
references: Pharmacogenomics. 2010 Feb;11(2):257-66
references: 20136364
references: Drug Alcohol Depend. 2009 Apr 1;101(1-2):92-100
references: 19101098
references: Hum Mol Genet. 2008 Jul 15;17(14):2219-27
references: 18424454
references: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1722-7
references: 18687376
references: Pharmacol Rev. 2005 Mar;57(1):1-26
references: 15734726
references: Pharmacogenet Genomics. 2005 Oct;15(10):693-704
references: 16141795
references: Drug Alcohol Depend. 2002 Feb 1;65(3):283-90
references: 11841899
references: Biochem Biophys Res Commun. 2004 Jul 9;319(4):1322-6
references: 15194512
references: Drug Alcohol Depend. 2006 Jan 4;81(1):55-61
references: 15993552
references: Clin Pharmacol Ther. 2004 Sep;76(3):250-69
references: 15371986
references: Drug Alcohol Depend. 2006 Jun 28;83(2):174-80
references: 16343809
references: J Clin Psychopharmacol. 2009 Jun;29(3):231-8
references: 19440076
references: Br J Clin Pharmacol. 2004 Dec;58(6):609-17
references: 15563359
references: Br J Clin Pharmacol. 2009 Jan;67(1):29-37
references: 19133059
references: N Engl J Med. 2000 Nov 2;343(18):1290-7
references: 11058673
references: Addiction. 2000 Dec;95(12):1771-83
references: 11177493
references: Br J Clin Pharmacol. 1993 Jan;35(1):30-4
references: 8448065
references: N Engl J Med. 2003 Feb 6;348(6):538-49
references: 12571262
references: Electrophoresis. 2003 Jun;24(12-13):2106-2110
references: 12858382
references: Clin Chem. 1992 Mar;38(3):438-9
references: 1547571
references: Am J Psychiatry. 2006 Apr;163(4):689-96
references: 16585445
references: Pharmacogenet Genomics. 2009 Jun;19(6):407-14
references: 19373123
references: Drug Alcohol Rev. 2009 Nov;28(6):608-15
references: 19930013
references: Drug Alcohol Depend. 2007 Jul 10;89(2-3):190-4
references: 17234366
references: Br J Clin Pharmacol. 1999 Apr;47(4):403-12
references: 10233205
references: Am J Psychiatry. 2004 Jul;161(7):1231-7
references: 15229056
references: Arch Gen Psychiatry. 1981 Aug;38(8):875-80
references: 7259424
references: J Clin Psychopharmacol. 2009 Feb;29(1):77-81
references: 19142113
references: AAPS J. 2006 Aug 18;8(3):E515-20
references: 17025270